Packages - Shine Functional Health

Wellness packages

focus on your health
  • List Item
  • List Item
  • List Item
  • List Item
  • List Item
  • List Item
  • List Item
  • List Item
  • List Item
  • List Item

Between ages 40 and 55, men can experience the male equivalent of menopause, and this is now referred to as andropause or “menopause”. Virtually all men will experience a decline in hormone levels with age. For example, the average testosterone level of a 70-year-old man is ten times lower than that of a 25-year-old man. According to the April 2006 issue of the American Journal of Therapy, the circulating testosterone level declines steadily from age 19 at an average rate of 1% per year. By age 70, about one in every three men has very low serum total testosterone levels.

Between ages 40 and 55, men can experience the male equivalent of menopause, and this is now referred to as andropause or “menopause”. Virtually all men will experience a decline in hormone levels with age. For example, the average testosterone level of a 70-year-old man is ten times lower than that of a 25-year-old man. According to the April 2006 issue of the American Journal of Therapy, the circulating testosterone level declines steadily from age 19 at an average rate of 1% per year. By age 70, about one in every three men has very low serum total testosterone levels.

The two leading causes of death for U.S. men and women over the age of 50 are heart attacks and strokes. Atherosclerosis, or “hardening of the arteries,” is typically involved in the pathogenesis of these conditions. The initial focus of our approach is to use nutritional therapies and lifestyle modifications to reduce various risk factors that predispose an individual to atherosclerosis—factors such as a high ratio of total cholesterol to high-density lipoproteins, and elevated blood levels of homocysteine, fibrinogen, insulin, or C-reactive protein. In addition, we favor the use of therapies that are aimed at removing plaque and restoring blood flow throughout the entire circulatory system. This includes therapies that remove calcifications from blood vessels and eradicate the underlying causes of these calcifications.

We have treated a number of patients with autoimmune disorders such as rheumatoid arthritis, lupus, multiple sclerosis, Crohn’s disease, scleroderma, psoriasis, and dermatomyositis. Multiple therapies are often utilized in treating these patients, including targeted support for cellular and intestinal detoxification processes, and the correction of nutritional deficiencies. Overall, the goal is to calm down the immune system rather than increase its activity. In many cases, toxic factors or infectious agents may trigger or further amplify these autoimmune processes, and combinations of innovative therapies have shown the potential to resolve these health problems.

Scroll to Top